Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance
- Tuesday, November 8, 2022, 7:05
- Finance
- Add a comment
Launched Terlivaz® Following U.S. Food and Drug Administration (FDA) Approval in September; Submitted U.S. FDA Premarket Notification Application for Next-Generation Delivery System of INOmax® Strengthened Organization with Appointment of New Executives and Directors; Ordinary Shares…
About the Author
adminasapcorp has written 41789 stories on this site.